Obstetrician–gynecologists’ practices and attitudes on substance use screening during pregnancy

Abstract

Objective: To describe obstetrician-gynecologists' practices and attitudes related to substance use screening in pregnant patients. Study Design:A 2017 cross-sectional survey assessed U.S. obstetrician-gynecologists' (n=462; response rate=34%) practices (substance use screening frequency and methods) and attitudes (practice priority of screening, confidence in treating, and responsibility statements). Chi-squared tests and adjusted modified Poisson regression were used to estimate associations between practices and attitudes.Results: Of 353 respondents with screening information, 79% frequently screen for substance use and 11% used a validated instrument. Confidence was highest for treating pregnant patients Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:

Obstetrician–gynecologists’ practice patterns related to opioid use during pregnancy and postpartum—United States, 2017

“…The overall response rate was 34% (N = 462). Respondents had a mean of 20 years in practice, 63% were female, and 12% were board certified in maternal-fetal medicine (data reported elsewhere) (16). More than 72% of respondents indicated that over a quarter of their patients were insured by Medicaid (16).…”

“…Investigators from ACOG and the Centers for Disease Control and Prevention (CDC) collaboratively developed a cross-sectional survey to assess obstetrician-gynecologists' reported experiences, opinions, and practices regarding women's substance use during pregnancy and postpartum. Specifically, the survey included questions about frequency and method of substance use screening (e.g., alcohol, tobacco, marijuana, illicit substances), which are reported elsewhere (16), and questions on practices, knowledge, perceptions of preparedness and confidence for managing opioid use among pregnant and postpartum women, and potential resources needed for and barriers to effective treatment of opioid use disorder, which are reported on in this manuscript. ACOG received local IRB approval; survey completion was considered consent to participate.…”

“…ACOG received local IRB approval; survey completion was considered consent to participate. Additional methodological details regarding survey design and participants can be found elsewhere (16).…”

“…The Massachusetts Child Psychiatry Access Program for Moms, is an innovative example of building capacity within perinatal primary care providers to address perinatal mental health and substance use through the provision of near-time telephonic clinical consultations from perinatal psychiatrist colleagues, as well as provision of trainings, tool kits, and referrals to community resources (19). Obstetrician-gynecologists frequently screen for substance use (16). Taking patient histories and using verbal screening tools provide the opportunity for the prenatal care clinician to offer brief intervention or motivational interviewing (6,20).…”

“…In a preceding analysis, we investigated uptake of ACOG's universal substance use screening recommendations and found that 79% of respondents reported frequently screening for substance use among their pregnant patients (16). We also found that 55% and 61% of obstetrician-gynecologists perceived that screening for medical and non-medical use of prescription opioids, respectively, is a high priority for their practices.…”